Auven Therapeutics is a private equity company focused on the healthcare industry. We pursuing an innovative life science investment strategy. Although it utilizes a fund structure, it also has an internal drug development company that allows it to more effectively manage drug development and grow the value of its therapeutic assets. Auven Therapeutics seeks to identify, acquire and/or partner and then invest in the development of novel therapeutic product candidates (both small-molecules and biologics) with a focus on mid-stage clinical development candidates.
Auven Therapeutics invests according to the following criteria:
-Human proof-of-concept established
-Attractive commercial opportunity
-Compelling product profile that addresses a critical unmet medical need
-Strong intellectual property or other commercially relevant protection of the asset
-Executable clinical plan
-Conservative regulatory plan
-Well-defined pathway to a commercial manufacturing process
People
- Stephen Evans-Freke, Co-Founder and Managing General Partner
You last contacted this investor on .